Stay updated on Phase 2a Safety of MEDI8852 in Influenza Clinical Trial
Sign up to get notified when there's something new on the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page.

Latest updates to the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter revision label updated from Revision: v3.6.3 to Revision: v3.6.4, representing a minor update to the page's versioning metadata.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe footer now displays Revision: v3.6.3, replacing the previous v3.6.2, indicating a platform update. This reflects a software version change rather than a modification to study data or navigation elements.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page footer updated from revision v3.6.0 to v3.6.2. This reflects a small platform/template update rather than a substantive change to the study details.SummaryDifference0.0%

- Check56 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' indicating that participant enrollment is closed. Added user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated the footer to Revision: v3.6.0, while replacing the label 'Intervention / Treatment' with 'Intervention/Treatment' and removing the previous revision 'v3.5.5'.SummaryDifference0.3%

- Check63 days agoChange DetectedThe page revision indicator changed from v3.5.4 to v3.5.5. This appears to be a small internal update and does not modify the study information shown.SummaryDifference0.0%

- Check85 days agoChange DetectedThe revision label on the page was updated from v3.5.3 to v3.5.4, indicating a subsequent update to the page metadata. This change reflects an incremental update to the record without altering the primary study information.SummaryDifference0.0%

Stay in the know with updates to Phase 2a Safety of MEDI8852 in Influenza Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page.